Join FHI 360 for a two-day virtual symposium with global experts in infectious diseases and global health security to discuss the emerging consequences of the intersection between the COVID-19 pandemic and antimicrobial resistance (AMR).
AMR is a global public health threat with a substantial human and economic impact. It occurs when bacteria, fungi and parasites stop responding to and become resistant to antimicrobial medications. The scale of AMR has increased rapidly in recent years, especially in countries where regulations that control antibiotic prescription and use in humans and animals are weak or nonexistent.
The COVID-19 pandemic may have long-term consequences on the continued global emergence and acceleration of AMR, and researchers are exploring how antibiotic use changed during this time. Countries and health systems need to act now to address this public health threat.
This symposium, hosted by FHI 360’s Emerging Infectious Diseases and Health Security Division, will provide thought leadership on how increased and inappropriate use of antibiotics during a pandemic can lead to undesirable consequences.
Sessions will address these topics:
- Antibiotic use and misuse during the pandemic: Implications for the future of AMR
- The role and importance of laboratory diagnostics in mitigating the impact of AMR
- The importance of integrating AMR stewardship measures into country-level pandemic response
- One Health: Zoonoses implications for AMR
